It is essential to undertake research to identify specific downstream targets of the Wnt/β-catenin pathway activated by PTTG1 in hepatocellular carcinoma (HCC) to elucidate their contributions to tumor progression and poor prognosis. This evidence concerns the gene PTTG1 and neoplasm.